General Information of Drug Transporter (DT)
DT ID DTD0319 Transporter Info
Gene Name SLC36A2
Transporter Name Proton-coupled amino acid transporter 2
Gene ID
153201
UniProt ID
Q495M3
Epigenetic Regulations of This DT (EGR)

Methylation

  Bladder cancer

           8 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC36A2 in bladder cancer [ 1 ]

Location

TSS1500 (cg22505977)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -2.94E+00 Statistic Test p-value: 9.53E-10; Z-score: -8.65E+00

Methylation in Case

1.80E-01 (Median) Methylation in Control 5.27E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC36A2 in bladder cancer [ 1 ]

Location

TSS1500 (cg10345936)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.34E+00 Statistic Test p-value: 4.76E-08; Z-score: -9.04E+00

Methylation in Case

5.98E-01 (Median) Methylation in Control 8.01E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC36A2 in bladder cancer [ 1 ]

Location

TSS1500 (cg23502298)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.77E+00 Statistic Test p-value: 3.98E-04; Z-score: -2.99E+00

Methylation in Case

1.53E-01 (Median) Methylation in Control 2.71E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC36A2 in bladder cancer [ 1 ]

Location

TSS1500 (cg24780796)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.36E+00 Statistic Test p-value: 2.64E-03; Z-score: -1.89E+00

Methylation in Case

3.82E-01 (Median) Methylation in Control 5.20E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC36A2 in bladder cancer [ 1 ]

Location

TSS200 (cg18723442)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -2.47E+00 Statistic Test p-value: 9.25E-10; Z-score: -9.11E+00

Methylation in Case

2.13E-01 (Median) Methylation in Control 5.25E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC36A2 in bladder cancer [ 1 ]

Location

Body (cg05672174)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -2.51E+00 Statistic Test p-value: 4.63E-12; Z-score: -1.14E+01

Methylation in Case

2.80E-01 (Median) Methylation in Control 7.04E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC36A2 in bladder cancer [ 1 ]

Location

Body (cg24131671)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.90E+00 Statistic Test p-value: 1.03E-10; Z-score: -1.73E+01

Methylation in Case

3.60E-01 (Median) Methylation in Control 6.83E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of SLC36A2 in bladder cancer [ 1 ]

Location

3'UTR (cg25380622)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.88E+00 Statistic Test p-value: 3.48E-03; Z-score: -2.53E+00

Methylation in Case

6.93E-02 (Median) Methylation in Control 1.30E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Breast cancer

           9 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC36A2 in breast cancer [ 2 ]

Location

TSS1500 (cg23502298)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.42E+00 Statistic Test p-value: 2.30E-09; Z-score: -1.81E+00

Methylation in Case

3.45E-01 (Median) Methylation in Control 4.89E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC36A2 in breast cancer [ 2 ]

Location

TSS1500 (cg10345936)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.06E+00 Statistic Test p-value: 4.63E-04; Z-score: -7.52E-01

Methylation in Case

6.76E-01 (Median) Methylation in Control 7.17E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC36A2 in breast cancer [ 2 ]

Location

TSS1500 (cg22505977)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.18E+00 Statistic Test p-value: 3.82E-03; Z-score: -9.82E-01

Methylation in Case

3.69E-01 (Median) Methylation in Control 4.35E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC36A2 in breast cancer [ 2 ]

Location

TSS1500 (cg24780796)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.10E+00 Statistic Test p-value: 1.09E-02; Z-score: -7.44E-01

Methylation in Case

5.27E-01 (Median) Methylation in Control 5.81E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC36A2 in breast cancer [ 2 ]

Location

TSS200 (cg18723442)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.45E+00 Statistic Test p-value: 2.39E-10; Z-score: 2.13E+00

Methylation in Case

3.75E-01 (Median) Methylation in Control 2.59E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC36A2 in breast cancer [ 2 ]

Location

Body (ch.5.2843133R)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -2.14E+00 Statistic Test p-value: 1.26E-10; Z-score: -1.54E+00

Methylation in Case

6.92E-02 (Median) Methylation in Control 1.48E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC36A2 in breast cancer [ 2 ]

Location

Body (cg05672174)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.15E+00 Statistic Test p-value: 1.42E-10; Z-score: -2.11E+00

Methylation in Case

6.27E-01 (Median) Methylation in Control 7.18E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of SLC36A2 in breast cancer [ 2 ]

Location

Body (cg24131671)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.06E+00 Statistic Test p-value: 2.56E-03; Z-score: -7.22E-01

Methylation in Case

6.63E-01 (Median) Methylation in Control 7.00E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 9

Methylation of SLC36A2 in breast cancer [ 2 ]

Location

3'UTR (cg25380622)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.20E+00 Statistic Test p-value: 4.70E-05; Z-score: -6.87E-01

Methylation in Case

8.14E-02 (Median) Methylation in Control 9.77E-02 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Colorectal cancer

           7 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC36A2 in colorectal cancer [ 3 ]

Location

TSS1500 (cg10345936)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.28E+00 Statistic Test p-value: 5.38E-15; Z-score: -5.84E+00

Methylation in Case

6.40E-01 (Median) Methylation in Control 8.21E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC36A2 in colorectal cancer [ 3 ]

Location

TSS1500 (cg22505977)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.35E+00 Statistic Test p-value: 1.37E-10; Z-score: -2.56E+00

Methylation in Case

4.92E-01 (Median) Methylation in Control 6.63E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC36A2 in colorectal cancer [ 3 ]

Location

TSS1500 (cg24780796)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.11E+00 Statistic Test p-value: 1.35E-07; Z-score: -1.46E+00

Methylation in Case

6.64E-01 (Median) Methylation in Control 7.37E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC36A2 in colorectal cancer [ 3 ]

Location

TSS200 (cg18723442)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.10E+00 Statistic Test p-value: 7.08E-05; Z-score: -1.24E+00

Methylation in Case

6.65E-01 (Median) Methylation in Control 7.29E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC36A2 in colorectal cancer [ 3 ]

Location

Body (cg24131671)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.20E+00 Statistic Test p-value: 6.93E-10; Z-score: -2.53E+00

Methylation in Case

6.54E-01 (Median) Methylation in Control 7.85E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC36A2 in colorectal cancer [ 3 ]

Location

Body (cg05672174)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.06E+00 Statistic Test p-value: 1.51E-07; Z-score: -2.27E+00

Methylation in Case

8.08E-01 (Median) Methylation in Control 8.57E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Hepatocellular carcinoma

           6 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC36A2 in hepatocellular carcinoma [ 4 ]

Location

TSS1500 (cg07488506)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.32E+00 Statistic Test p-value: 2.12E-10; Z-score: -3.92E+00

Methylation in Case

5.01E-01 (Median) Methylation in Control 6.64E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC36A2 in hepatocellular carcinoma [ 4 ]

Location

TSS1500 (cg22505977)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.36E+00 Statistic Test p-value: 7.95E-08; Z-score: -2.01E+00

Methylation in Case

4.03E-01 (Median) Methylation in Control 5.47E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC36A2 in hepatocellular carcinoma [ 4 ]

Location

TSS1500 (cg10345936)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.28E+00 Statistic Test p-value: 2.11E-06; Z-score: -1.99E+00

Methylation in Case

4.42E-01 (Median) Methylation in Control 5.66E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC36A2 in hepatocellular carcinoma [ 4 ]

Location

TSS1500 (cg24780796)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.17E+00 Statistic Test p-value: 8.63E-04; Z-score: -9.78E-01

Methylation in Case

3.54E-01 (Median) Methylation in Control 4.16E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC36A2 in hepatocellular carcinoma [ 4 ]

Location

Body (cg11328253)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.16E+00 Statistic Test p-value: 3.28E-10; Z-score: -3.55E+00

Methylation in Case

6.66E-01 (Median) Methylation in Control 7.70E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC36A2 in hepatocellular carcinoma [ 4 ]

Location

3'UTR (cg25380622)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.17E+00 Statistic Test p-value: 1.29E-05; Z-score: -9.41E-01

Methylation in Case

8.09E-02 (Median) Methylation in Control 9.50E-02 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  HIV infection

           4 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC36A2 in HIV infection [ 5 ]

Location

TSS1500 (cg22505977)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.09E+00 Statistic Test p-value: 4.73E-04; Z-score: -9.22E-01

Methylation in Case

6.75E-01 (Median) Methylation in Control 7.34E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC36A2 in HIV infection [ 5 ]

Location

TSS1500 (cg10345936)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.06E+00 Statistic Test p-value: 7.33E-04; Z-score: -1.22E+00

Methylation in Case

7.99E-01 (Median) Methylation in Control 8.47E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC36A2 in HIV infection [ 5 ]

Location

TSS1500 (cg23502298)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.11E+00 Statistic Test p-value: 1.39E-02; Z-score: -5.53E-01

Methylation in Case

3.08E-01 (Median) Methylation in Control 3.42E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC36A2 in HIV infection [ 5 ]

Location

Body (cg24131671)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.03E+00 Statistic Test p-value: 5.42E-04; Z-score: -8.50E-01

Methylation in Case

8.47E-01 (Median) Methylation in Control 8.76E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Lung adenocarcinoma

           2 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC36A2 in lung adenocarcinoma [ 6 ]

Location

TSS1500 (cg10345936)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.08E+00 Statistic Test p-value: 4.03E-02; Z-score: -1.53E+00

Methylation in Case

7.16E-01 (Median) Methylation in Control 7.71E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC36A2 in lung adenocarcinoma [ 6 ]

Location

3'UTR (cg25380622)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.19E+00 Statistic Test p-value: 4.21E-02; Z-score: -1.06E+00

Methylation in Case

1.20E-01 (Median) Methylation in Control 1.43E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Pancretic ductal adenocarcinoma

           5 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC36A2 in pancretic ductal adenocarcinoma [ 7 ]

Location

TSS1500 (cg22797991)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.39E+00 Statistic Test p-value: 3.13E-04; Z-score: 8.91E-01

Methylation in Case

2.62E-01 (Median) Methylation in Control 1.88E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC36A2 in pancretic ductal adenocarcinoma [ 7 ]

Location

TSS200 (cg08352268)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -2.25E+00 Statistic Test p-value: 1.42E-05; Z-score: -1.05E+00

Methylation in Case

1.13E-01 (Median) Methylation in Control 2.55E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC36A2 in pancretic ductal adenocarcinoma [ 7 ]

Location

Body (cg03569283)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.01E+00 Statistic Test p-value: 1.50E-07; Z-score: -6.28E-01

Methylation in Case

8.84E-01 (Median) Methylation in Control 8.95E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC36A2 in pancretic ductal adenocarcinoma [ 7 ]

Location

Body (cg06955716)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.24E+00 Statistic Test p-value: 6.38E-04; Z-score: 1.26E+00

Methylation in Case

7.56E-01 (Median) Methylation in Control 6.11E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC36A2 in pancretic ductal adenocarcinoma [ 7 ]

Location

3'UTR (cg20059682)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.04E+00 Statistic Test p-value: 2.39E-03; Z-score: 6.57E-01

Methylation in Case

8.50E-01 (Median) Methylation in Control 8.19E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Papillary thyroid cancer

           2 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC36A2 in papillary thyroid cancer [ 8 ]

Location

TSS1500 (cg10345936)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.07E+00 Statistic Test p-value: 1.08E-09; Z-score: -1.91E+00

Methylation in Case

8.34E-01 (Median) Methylation in Control 8.95E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC36A2 in papillary thyroid cancer [ 8 ]

Location

3'UTR (cg25380622)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.08E+00 Statistic Test p-value: 7.08E-03; Z-score: 5.15E-01

Methylation in Case

8.26E-02 (Median) Methylation in Control 7.62E-02 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Prostate cancer

           5 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC36A2 in prostate cancer [ 9 ]

Location

TSS1500 (cg18639125)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 2.37E+00 Statistic Test p-value: 3.32E-02; Z-score: 4.62E+00

Methylation in Case

3.49E-01 (Median) Methylation in Control 1.48E-01 (Median)

Studied Phenotype

Prostate cancer [ ICD-11: 2C82]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC36A2 in prostate cancer [ 9 ]

Location

TSS200 (cg07496545)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.29E+00 Statistic Test p-value: 2.55E-02; Z-score: 2.00E+00

Methylation in Case

7.99E-01 (Median) Methylation in Control 6.20E-01 (Median)

Studied Phenotype

Prostate cancer [ ICD-11: 2C82]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC36A2 in prostate cancer [ 9 ]

Location

Body (cg10184441)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.32E+00 Statistic Test p-value: 2.35E-02; Z-score: -2.90E+00

Methylation in Case

5.52E-01 (Median) Methylation in Control 7.26E-01 (Median)

Studied Phenotype

Prostate cancer [ ICD-11: 2C82]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC36A2 in prostate cancer [ 9 ]

Location

Body (cg18447419)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.47E+00 Statistic Test p-value: 2.40E-02; Z-score: -5.66E+00

Methylation in Case

4.02E-01 (Median) Methylation in Control 5.91E-01 (Median)

Studied Phenotype

Prostate cancer [ ICD-11: 2C82]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Significant hypermethylation of SLC36A2 in prostate cancer than that in healthy individual

Studied Phenotype

Prostate cancer [ICD-11:2C82]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 0.003699362; Fold-change: 0.64521256; Z-score: 1.894144067
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Systemic lupus erythematosus

           5 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC36A2 in systemic lupus erythematosus [ 10 ]

Location

TSS1500 (cg23502298)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.05E+00 Statistic Test p-value: 1.80E-02; Z-score: -2.13E-01

Methylation in Case

3.61E-01 (Median) Methylation in Control 3.79E-01 (Median)

Studied Phenotype

Systemic lupus erythematosus [ ICD-11: 4A40.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC36A2 in systemic lupus erythematosus [ 10 ]

Location

TSS1500 (cg10345936)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.01E+00 Statistic Test p-value: 3.74E-02; Z-score: -1.24E-01

Methylation in Case

8.02E-01 (Median) Methylation in Control 8.11E-01 (Median)

Studied Phenotype

Systemic lupus erythematosus [ ICD-11: 4A40.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC36A2 in systemic lupus erythematosus [ 10 ]

Location

TSS200 (cg18723442)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.01E+00 Statistic Test p-value: 4.03E-02; Z-score: -1.41E-01

Methylation in Case

7.18E-01 (Median) Methylation in Control 7.25E-01 (Median)

Studied Phenotype

Systemic lupus erythematosus [ ICD-11: 4A40.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC36A2 in systemic lupus erythematosus [ 10 ]

Location

Body (cg24131671)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.02E+00 Statistic Test p-value: 3.66E-03; Z-score: -2.42E-01

Methylation in Case

8.56E-01 (Median) Methylation in Control 8.70E-01 (Median)

Studied Phenotype

Systemic lupus erythematosus [ ICD-11: 4A40.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC36A2 in systemic lupus erythematosus [ 10 ]

Location

Body (cg05672174)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.01E+00 Statistic Test p-value: 7.55E-03; Z-score: -1.80E-01

Methylation in Case

8.56E-01 (Median) Methylation in Control 8.62E-01 (Median)

Studied Phenotype

Systemic lupus erythematosus [ ICD-11: 4A40.0]

Experimental Material

Patient tissue samples

  Atypical teratoid rhabdoid tumor

           2 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC36A2 in atypical teratoid rhabdoid tumor [ 11 ]

Location

Body (cg05672174)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.77E+00 Statistic Test p-value: 1.62E-03; Z-score: -9.34E-01

Methylation in Case

1.60E-01 (Median) Methylation in Control 2.83E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC36A2 in atypical teratoid rhabdoid tumor [ 11 ]

Location

3'UTR (cg25380622)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.25E+00 Statistic Test p-value: 2.05E-09; Z-score: -1.55E+00

Methylation in Case

6.08E-01 (Median) Methylation in Control 7.63E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Panic disorder

           2 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC36A2 in panic disorder [ 12 ]

Location

Body (cg24131671)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.07E+00 Statistic Test p-value: 2.18E-02; Z-score: 5.40E-01

Methylation in Case

2.64E+00 (Median) Methylation in Control 2.47E+00 (Median)

Studied Phenotype

Panic disorder [ ICD-11: 6B01]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC36A2 in panic disorder [ 12 ]

Location

Body (ch.5.2843133R)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 9.37E-01 Statistic Test p-value: 3.15E-02; Z-score: 1.91E-01

Methylation in Case

-1.88E+00 (Median) Methylation in Control -2.00E+00 (Median)

Studied Phenotype

Panic disorder [ ICD-11: 6B01]

Experimental Material

Patient tissue samples

  Liver cancer

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Moderate/significant/moderate hypomethylation of SLC36A2 in liver cancer disease than that in healthy individual/adjacent tissue/other disease section

Studied Phenotype

Liver cancer [ICD-11:2C12]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 0.00102033; Fold-change: -0.292573846; Z-score: -1.36307981

The Methylation Level of Disease Section Compare with the Adjacent Tissue

p-value: 3.97E-14; Fold-change: -0.403715315; Z-score: -4.244107129

The Methylation Level of Disease Section Compare with the Other Disease Section

p-value: 0.004719136; Fold-change: -0.200276231; Z-score: -0.911815952
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue adjacent to the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
DT methylation level in tissue other than the diseased tissue of patients
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Squamous cell carcinoma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Moderate/moderate hypomethylation of SLC36A2 in squamous cell carcinoma than that in healthy individual/adjacent tissue

Studied Phenotype

Squamous cell carcinoma [ICD-11:2B60]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 0.00014598; Fold-change: -0.241722075; Z-score: -2.340278002

The Methylation Level of Disease Section Compare with the Adjacent Tissue

p-value: 2.04E-05; Fold-change: -0.205445716; Z-score: -3.137211987
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue adjacent to the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals

  Obesity

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Moderate hypomethylation of SLC36A2 in obesity than that in healthy individual

Studied Phenotype

Obesity [ICD-11:5B81]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 1.18E-06; Fold-change: -0.24427136; Z-score: -2.772353006
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  RELA YAP fusion ependymoma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Moderate hypomethylation of SLC36A2 in rela yap fusion ependymoma than that in healthy individual

Studied Phenotype

RELA YAP fusion ependymoma [ICD-11:2A00.0Y]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 5.65E-07; Fold-change: -0.270024473; Z-score: -1.049081949
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Central neurocytoma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Significant hypermethylation of SLC36A2 in central neurocytoma than that in healthy individual

Studied Phenotype

Central neurocytoma [ICD-11:2A00.3]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 0.008609341; Fold-change: 0.402458036; Z-score: 1.117309692
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Third ventricle chordoid glioma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Significant hypermethylation of SLC36A2 in third ventricle chordoid glioma than that in healthy individual

Studied Phenotype

Third ventricle chordoid glioma [ICD-11:2A00.0Y]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 0.018292889; Fold-change: 0.491482002; Z-score: 1.264936079
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Brain neuroblastoma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Significant hypomethylation of SLC36A2 in brain neuroblastoma than that in healthy individual

Studied Phenotype

Brain neuroblastoma [ICD-11:2A00.11]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 4.51E-09; Fold-change: -0.612285311; Z-score: -1.838296426
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Chordoma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Significant hypomethylation of SLC36A2 in chordoma than that in healthy individual

Studied Phenotype

Chordoma [ICD-11:5A61.0]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 0.001860557; Fold-change: -0.378901214; Z-score: -2.436980053
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Diffuse midline glioma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Significant hypomethylation of SLC36A2 in diffuse midline glioma than that in healthy individual

Studied Phenotype

Diffuse midline glioma [ICD-11:2A00.0Z]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 3.75E-18; Fold-change: -0.377658701; Z-score: -1.53481132
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Esthesioneuroblastoma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Significant hypomethylation of SLC36A2 in esthesioneuroblastoma than that in healthy individual

Studied Phenotype

Esthesioneuroblastoma [ICD-11:2D50.1]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 4.09E-06; Fold-change: -0.630362837; Z-score: -1.755042733
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Lymphoma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Significant hypomethylation of SLC36A2 in lymphoma than that in healthy individual

Studied Phenotype

Lymphoma [ICD-11:2B30]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 6.25E-19; Fold-change: -0.652939387; Z-score: -2.132290264
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Medulloblastoma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Significant hypomethylation of SLC36A2 in medulloblastoma than that in healthy individual

Studied Phenotype

Medulloblastoma [ICD-11:2A00.10]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 6.90E-52; Fold-change: -0.316124184; Z-score: -2.350888403
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Melanoma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Significant hypomethylation of SLC36A2 in melanoma than that in healthy individual

Studied Phenotype

Melanoma [ICD-11:2C30]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 1.76E-05; Fold-change: -0.494588402; Z-score: -1.552776118
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Multilayered rosettes embryonal tumour

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Significant hypomethylation of SLC36A2 in multilayered rosettes embryonal tumour than that in healthy individual

Studied Phenotype

Multilayered rosettes embryonal tumour [ICD-11:2A00.1]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 0.013343577; Fold-change: -0.318561093; Z-score: -0.954602066
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Ovarian cancer

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Significant hypomethylation of SLC36A2 in ovarian cancer than that in healthy individual

Studied Phenotype

Ovarian cancer [ICD-11:2C73]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 0.039641747; Fold-change: -0.315209352; Z-score: -1.069284242
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Posterior fossa ependymoma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Significant hypomethylation of SLC36A2 in posterior fossa ependymoma than that in healthy individual

Studied Phenotype

Posterior fossa ependymoma [ICD-11:2D50.2]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 9.89E-50; Fold-change: -0.485425598; Z-score: -2.10536666
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Uterine carcinosarcoma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Significant hypomethylation of SLC36A2 in uterine carcinosarcoma than that in healthy individual

Studied Phenotype

Uterine carcinosarcoma [ICD-11:2B5F]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 0.01557231; Fold-change: -0.366174098; Z-score: -1.242645924
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

microRNA

  Unclear Phenotype

         31 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

miR-1227 directly targets SLC36A2 [ 13 ]

Epigenetic Type

microRNA Experiment Method PAR-CLIP

miRNA Stemloop ID

miR-1227 miRNA Mature ID miR-1227-3p

miRNA Sequence

CGUGCCACCCUUUUCCCCAG

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 2

miR-1827 directly targets SLC36A2 [ 14 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-1827 miRNA Mature ID miR-1827

miRNA Sequence

UGAGGCAGUAGAUUGAAU

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 3

miR-3689d directly targets SLC36A2 [ 13 ]

Epigenetic Type

microRNA Experiment Method PAR-CLIP

miRNA Stemloop ID

miR-3689d miRNA Mature ID miR-3689d

miRNA Sequence

GGGAGGUGUGAUCUCACACUCG

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 4

miR-377 directly targets SLC36A2 [ 13 ]

Epigenetic Type

microRNA Experiment Method PAR-CLIP

miRNA Stemloop ID

miR-377 miRNA Mature ID miR-377-5p

miRNA Sequence

AGAGGUUGCCCUUGGUGAAUUC

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 5

miR-3929 directly targets SLC36A2 [ 14 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-3929 miRNA Mature ID miR-3929

miRNA Sequence

GAGGCUGAUGUGAGUAGACCACU

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 6

miR-4478 directly targets SLC36A2 [ 14 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-4478 miRNA Mature ID miR-4478

miRNA Sequence

GAGGCUGAGCUGAGGAG

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 7

miR-4537 directly targets SLC36A2 [ 13 ]

Epigenetic Type

microRNA Experiment Method PAR-CLIP

miRNA Stemloop ID

miR-4537 miRNA Mature ID miR-4537

miRNA Sequence

UGAGCCGAGCUGAGCUUAGCUG

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 8

miR-455 directly targets SLC36A2 [ 13 ]

Epigenetic Type

microRNA Experiment Method PAR-CLIP

miRNA Stemloop ID

miR-455 miRNA Mature ID miR-455-3p

miRNA Sequence

GCAGUCCAUGGGCAUAUACAC

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 9

miR-4649 directly targets SLC36A2 [ 14 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-4649 miRNA Mature ID miR-4649-3p

miRNA Sequence

UCUGAGGCCUGCCUCUCCCCA

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 10

miR-4722 directly targets SLC36A2 [ 14 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-4722 miRNA Mature ID miR-4722-5p

miRNA Sequence

GGCAGGAGGGCUGUGCCAGGUUG

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 11

miR-4733 directly targets SLC36A2 [ 14 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-4733 miRNA Mature ID miR-4733-5p

miRNA Sequence

AAUCCCAAUGCUAGACCCGGUG

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 12

miR-4768 directly targets SLC36A2 [ 14 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-4768 miRNA Mature ID miR-4768-3p

miRNA Sequence

CCAGGAGAUCCAGAGAGAAU

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 13

miR-485 directly targets SLC36A2 [ 14 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-485 miRNA Mature ID miR-485-5p

miRNA Sequence

AGAGGCUGGCCGUGAUGAAUUC

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 14

miR-5186 directly targets SLC36A2 [ 13 ]

Epigenetic Type

microRNA Experiment Method PAR-CLIP

miRNA Stemloop ID

miR-5186 miRNA Mature ID miR-5186

miRNA Sequence

AGAGAUUGGUAGAAAUCAGGU

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 15

miR-606 directly targets SLC36A2 [ 14 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-606 miRNA Mature ID miR-606

miRNA Sequence

AAACUACUGAAAAUCAAAGAU

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 16

miR-6086 directly targets SLC36A2 [ 13 ]

Epigenetic Type

microRNA Experiment Method PAR-CLIP

miRNA Stemloop ID

miR-6086 miRNA Mature ID miR-6086

miRNA Sequence

GGAGGUUGGGAAGGGCAGAG

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 17

miR-6134 directly targets SLC36A2 [ 13 ]

Epigenetic Type

microRNA Experiment Method PAR-CLIP

miRNA Stemloop ID

miR-6134 miRNA Mature ID miR-6134

miRNA Sequence

UGAGGUGGUAGGAUGUAGA

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 18

miR-6499 directly targets SLC36A2 [ 13 ]

Epigenetic Type

microRNA Experiment Method PAR-CLIP

miRNA Stemloop ID

miR-6499 miRNA Mature ID miR-6499-3p

miRNA Sequence

AGCAGUGUUUGUUUUGCCCACA

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 19

miR-6516 directly targets SLC36A2 [ 13 ]

Epigenetic Type

microRNA Experiment Method PAR-CLIP

miRNA Stemloop ID

miR-6516 miRNA Mature ID miR-6516-5p

miRNA Sequence

UUUGCAGUAACAGGUGUGAGCA

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 20

miR-665 directly targets SLC36A2 [ 13 ]

Epigenetic Type

microRNA Experiment Method PAR-CLIP

miRNA Stemloop ID

miR-665 miRNA Mature ID miR-665

miRNA Sequence

ACCAGGAGGCUGAGGCCCCU

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 21

miR-6746 directly targets SLC36A2 [ 14 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-6746 miRNA Mature ID miR-6746-5p

miRNA Sequence

CCGGGAGAAGGAGGUGGCCUGG

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 22

miR-6771 directly targets SLC36A2 [ 14 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-6771 miRNA Mature ID miR-6771-5p

miRNA Sequence

CUCGGGAGGGCAUGGGCCAGGC

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 23

miR-6808 directly targets SLC36A2 [ 14 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-6808 miRNA Mature ID miR-6808-5p

miRNA Sequence

CAGGCAGGGAGGUGGGACCAUG

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 24

miR-6840 directly targets SLC36A2 [ 13 ]

Epigenetic Type

microRNA Experiment Method PAR-CLIP

miRNA Stemloop ID

miR-6840 miRNA Mature ID miR-6840-3p

miRNA Sequence

GCCCAGGACUUUGUGCGGGGUG

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 25

miR-6851 directly targets SLC36A2 [ 13 ]

Epigenetic Type

microRNA Experiment Method PAR-CLIP

miRNA Stemloop ID

miR-6851 miRNA Mature ID miR-6851-5p

miRNA Sequence

AGGAGGUGGUACUAGGGGCCAGC

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 26

miR-6880 directly targets SLC36A2 [ 13 ]

Epigenetic Type

microRNA Experiment Method PAR-CLIP

miRNA Stemloop ID

miR-6880 miRNA Mature ID miR-6880-5p

miRNA Sequence

UGGUGGAGGAAGAGGGCAGCUC

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 27

miR-6884 directly targets SLC36A2 [ 14 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-6884 miRNA Mature ID miR-6884-5p

miRNA Sequence

AGAGGCUGAGAAGGUGAUGUUG

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 28

miR-6893 directly targets SLC36A2 [ 14 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-6893 miRNA Mature ID miR-6893-5p

miRNA Sequence

CAGGCAGGUGUAGGGUGGAGC

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 29

miR-7160 directly targets SLC36A2 [ 14 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-7160 miRNA Mature ID miR-7160-5p

miRNA Sequence

UGCUGAGGUCCGGGCUGUGCC

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 30

miR-7847 directly targets SLC36A2 [ 13 ]

Epigenetic Type

microRNA Experiment Method PAR-CLIP

miRNA Stemloop ID

miR-7847 miRNA Mature ID miR-7847-3p

miRNA Sequence

CGUGGAGGACGAGGAGGAGGC

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 31

miR-940 directly targets SLC36A2 [ 14 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-940 miRNA Mature ID miR-940

miRNA Sequence

AAGGCAGGGCCCCCGCUCCCC

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human
References
1 DNA Methylation Dynamics in Urological Tumors.
2 Genome-wide Scan for Methylation Profiles in Breast Cancer
3 Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer. Gastroenterology. 2014 Aug;147(2):418-29.e8.
4 Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips. Epigenetics. 2013 Jan;8(1):34-43.
5 HIV-1 Infection Accelerates Age According to the Epigenetic Clock. J Infect Dis. 2015 Nov 15;212(10):1563-73.
6 DNA methylation analysis of lung adenocarcinoma and adjacent non-tumor tissues
7 Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling. Int J Cancer. 2014 Sep 1;135(5):1110-8.
8 Prognostic Classifier Based on Genome-Wide DNA Methylation Profiling in Well-Differentiated Thyroid Tumors. J Clin Endocrinol Metab. 2017 Nov 1;102(11):4089-4099.
9 Reducing the risk of false discovery enabling identification of biologically significant genome-wide methylation status using the HumanMethylation450 array. BMC Genomics. 2014 Jan 22;15:51.
10 Genome-wide DNA methylation analysis of systemic lupus erythematosus reveals persistent hypomethylation of interferon genes and compositional changes to CD4+ T-cell populations. PLoS Genet. 2013;9(8):e1003678.
11 Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes. Cancer Cell. 2016 Mar 14;29(3):379-393.
12 DNA Methylation signatures in panic disorder. Transl Psychiatry. 2017 Dec 18;7(12):1287.
13 TP53 regulates miRNA association with AGO2 to remodel the miRNA-mRNA interaction network. Genome Res. 2016 Mar;26(3):331-41.
14 Direct conversion of fibroblasts to neurons by reprogramming PTB-regulated microRNA circuits. Cell. 2013 Jan 17;152(1-2):82-96.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.